Standout Papers

Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. 1996 2026 2006 2016 603
  1. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. (1996)
    Sandro Rossi, M. Stasi et al. American Journal of Roentgenology

Immediate Impact

3 from Science/Nature 80 standout
Sub-graph 1 of 18

Citing Papers

Oxytocin, Vasopressin, and Social Behavior: From Neural Circuits to Clinical Opportunities
2022 Standout
Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia
2021 Standout
7 intermediate papers

Works of Lisa Squassante being referenced

A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder
2019
Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy—a [123I]CNS-1261 SPET study
2008
and 1 more

Author Peers

Author Last Decade Papers Cites
Lisa Squassante 217 413 214 535 366 48 1.9k
Yan Han 484 533 205 101 189 87 2.0k
Jean‐François Giguère 251 328 243 497 543 52 2.1k
Wen Xie 383 327 242 295 382 107 1.6k
Barry H. Guzé 98 575 168 136 178 58 2.3k
Thomas Ernst 207 1078 91 180 275 60 2.5k
Ralf Wimmer 410 1539 94 245 362 62 2.7k
Chia‐Hsiang Chen 969 569 241 380 574 149 3.1k
Sam R. Miller 154 108 211 127 198 37 1.6k
F Grünhage 357 215 190 857 1070 87 2.7k
Yong Sik Kim 179 173 96 113 208 107 1.9k

All Works

Loading papers...

Rankless by CCL
2026